Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co-developed by LEPU BIOPHARMA and HANX BIOPHARMACEUTICALS was approved for marketing in China by NMPA 2022-07-25 18:47
Fuzhou Rides on the Opportunity of "Digital China" to Make Its Name in the World 2022-07-25 15:21
Qiming's Portfolio Company InventisBio Lists on STAR Market 2022-07-25 11:55
4DMedical Lauds U.S. House of Representatives for Including Burn Pit Population Surveillance in FY 2023 Appropriations 2022-07-23 00:59
Nisun International Cooperates with Pinhutang Distillery to Facilitate Agricultural Product Purchases 2022-07-22 20:00
Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report 2022-07-22 19:25
TIANGEN to Participate in the 2022 AACC Meeting 2022-07-22 10:15
Ascentage Pharma Announces Clinical Trial Application for Olverembatinib (HQP1351) Approved in Canada 2022-07-22 07:59
uLab™ clear aligner platform is now available in Australia and New Zealand 2022-07-22 05:04
AI-based Cancer Solution Pioneer Lunit Makes Market Debut 2022-07-21 21:00
Waterdrop Launches Industry's First Customized Critical Illness Insurance Product with Waiver on Health Declarations 2022-07-21 18:00
ImmVira's intravenous administered oHSV MVR-T3011 IV demonstrated promising clinical biological activities 2022-07-21 08:00
Recruitment complete for Clarity's PROPELLER prostate cancer diagnostic trial 2022-07-20 21:06
Daewoong Pharmaceutical Gets First Korean US FDA Fast-Track for New Idiopathic Pulmonary Fibrosis Drug 2022-07-20 21:00
Ascentage Pharma and Innovent Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML 2022-07-20 00:15
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer 2022-07-19 20:00
OliPass Moves Forward to Second Stage of Phase 2a Trial for Pain Killer OLP-1002 2022-07-18 20:00
I-Mab to Present Phase 2 Clinical Data of CD47 Antibody Lemzoparlimab at ESMO Congress 2022 2022-07-18 20:00
China Pharma Announced the Submission of a Plan of Compliance to NYSE American 2022-07-18 20:00
Samsung Biologics to purchase land for its second Bio Campus 2022-07-18 19:00
1 148 149 150 151 152 812